In the context of EBV, associated primarily with laryngeal cancer, the high expression of lncRNA H19 in EBV-positive individuals is significantly correlated with the occurrence of laryngeal cancer, likely via the transcriptional repressor EZH2 regulation [151]. The gene discussed is EZH2; the disease is laryngeal carcinoma.